Viemed Healthcare Inc (VMD.CA) Stock Fundamental Analysis
TSX:VMD - Toronto Stock Exchange - CA92663R1055 - Common Stock - Currency: CAD
VMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 16 industry peers in the Health Care Providers & Services industry. VMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make VMD a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year VMD was profitable.
In the past year VMD had a positive cash flow from operations.
VMD had positive earnings in each of the past 5 years.
VMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 6.16%, VMD belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
VMD has a Return On Equity of 8.47%. This is in the better half of the industry: VMD outperforms 76.19% of its industry peers.
With an excellent Return On Invested Capital value of 7.90%, VMD belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
VMD had an Average Return On Invested Capital over the past 3 years of 11.36%. This is above the industry average of 8.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.16% | ||
| ROE | 8.47% | ||
| ROIC | 7.9% |
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
1.3 Margins
The Profit Margin of VMD (5.42%) is better than 90.48% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
With an excellent Operating Margin value of 7.73%, VMD belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
In the last couple of years the Operating Margin of VMD has declined.
VMD's Gross Margin of 61.00% is amongst the best of the industry. VMD outperforms 90.48% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.73% | ||
| PM (TTM) | 5.42% | ||
| GM | 61% |
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
2. Health
2.1 Basic Checks
VMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
VMD has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, VMD has an improved debt to assets ratio.
2.2 Solvency
VMD has an Altman-Z score of 6.66. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.66, VMD belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
VMD has a debt to FCF ratio of 0.65. This is a very positive value and a sign of high solvency as it would only need 0.65 years to pay back of all of its debts.
VMD has a Debt to FCF ratio of 0.65. This is amongst the best in the industry. VMD outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that VMD is not too dependend on debt financing.
VMD has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. VMD outperforms 95.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.65 | ||
| Altman-Z | 6.66 |
ROIC/WACC0.94
WACC8.43%
2.3 Liquidity
A Current Ratio of 1.14 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Current ratio (1.14) which is comparable to the rest of the industry.
VMD has a Quick Ratio of 1.14. This is a bad value and indicates that VMD is not financially healthy enough and could expect problems in meeting its short term obligations.
VMD has a Quick ratio of 0.99. This is comparable to the rest of the industry: VMD outperforms 52.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 21.05% over the past year.
The Earnings Per Share has been decreasing by -6.17% on average over the past years.
The Revenue has grown by 27.38% in the past year. This is a very strong growth!
VMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.23% yearly.
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.71% yearly.
The Revenue is expected to grow by 21.44% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
VMD is valuated quite expensively with a Price/Earnings ratio of 34.83.
Based on the Price/Earnings ratio, VMD is valued cheaper than 80.95% of the companies in the same industry.
VMD is valuated rather expensively when we compare the Price/Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 19.28, the valuation of VMD can be described as rather expensive.
85.71% of the companies in the same industry are more expensive than VMD, based on the Price/Forward Earnings ratio.
VMD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.74.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.83 | ||
| Fwd PE | 19.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VMD is valued a bit cheaper than 76.19% of the companies in the same industry.
VMD's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.11 | ||
| EV/EBITDA | 9.09 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 54.71% in the coming years.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y65.14%
EPS Next 3Y54.71%
5. Dividend
5.1 Amount
No dividends for VMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VMD (12/21/2023, 7:00:00 PM)
10.45
+0.29 (+2.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners31.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap402.32M
Analysts80
Price Target19.25 (84.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-18.46%
Max EPS beat(2)18.81%
EPS beat(4)2
Avg EPS beat(4)8.43%
Min EPS beat(4)-18.46%
Max EPS beat(4)48.51%
EPS beat(8)3
Avg EPS beat(8)-0.69%
EPS beat(12)5
Avg EPS beat(12)22.7%
EPS beat(16)7
Avg EPS beat(16)24.4%
Revenue beat(2)1
Avg Revenue beat(2)1.01%
Min Revenue beat(2)-1.19%
Max Revenue beat(2)3.2%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)3.2%
Revenue beat(8)6
Avg Revenue beat(8)1.73%
Revenue beat(12)8
Avg Revenue beat(12)1.84%
Revenue beat(16)10
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)-5.45%
EPS NY rev (3m)-5.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)96920.2%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.83 | ||
| Fwd PE | 19.28 | ||
| P/S | 1.79 | ||
| P/FCF | 19.11 | ||
| P/OCF | 7.66 | ||
| P/B | 2.79 | ||
| P/tB | 3.87 | ||
| EV/EBITDA | 9.09 |
EPS(TTM)0.3
EY2.87%
EPS(NY)0.54
Fwd EY5.19%
FCF(TTM)0.55
FCFY5.23%
OCF(TTM)1.36
OCFY13.05%
SpS5.84
BVpS3.74
TBVpS2.7
PEG (NY)0.46
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.16% | ||
| ROE | 8.47% | ||
| ROCE | 11.15% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 12.03% | ||
| OM | 7.73% | ||
| PM (TTM) | 5.42% | ||
| GM | 61% | ||
| FCFM | 9.36% |
ROA(3y)13.66%
ROA(5y)13.79%
ROE(3y)18.18%
ROE(5y)20.63%
ROIC(3y)11.36%
ROIC(5y)13.33%
ROICexc(3y)16.33%
ROICexc(5y)18.87%
ROICexgc(3y)16.33%
ROICexgc(5y)18.87%
ROCE(3y)16.03%
ROCE(5y)18.81%
ROICexcg growth 3Y-20.42%
ROICexcg growth 5Y-25.33%
ROICexc growth 3Y-20.42%
ROICexc growth 5Y-25.33%
OM growth 3Y-18.23%
OM growth 5Y-20.06%
PM growth 3Y-24.99%
PM growth 5Y-23.88%
GM growth 3Y-4.35%
GM growth 5Y-3.72%
F-Score4
Asset Turnover1.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.65 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 116.84% | ||
| Cap/Sales | 13.98% | ||
| Interest Coverage | 24.31 | ||
| Cash Conversion | 118.48% | ||
| Profit Quality | 172.53% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 6.66 |
F-Score4
WACC8.43%
ROIC/WACC0.94
Cap/Depr(3y)152.39%
Cap/Depr(5y)165.61%
Cap/Sales(3y)14.43%
Cap/Sales(5y)13.89%
Profit Quality(3y)59.5%
Profit Quality(5y)83.35%
High Growth Momentum
Growth
EPS 1Y (TTM)21.05%
EPS 3Y-13.28%
EPS 5Y-6.17%
EPS Q2Q%133.33%
EPS Next Y75.07%
EPS Next 2Y65.14%
EPS Next 3Y54.71%
EPS Next 5YN/A
Revenue 1Y (TTM)27.38%
Revenue growth 3Y20.01%
Revenue growth 5Y24.23%
Sales Q2Q%38.14%
Revenue Next Year31.41%
Revenue Next 2Y25.78%
Revenue Next 3Y21.44%
Revenue Next 5YN/A
EBIT growth 1Y35.22%
EBIT growth 3Y-1.87%
EBIT growth 5Y-0.68%
EBIT Next Year275.8%
EBIT Next 3Y76.08%
EBIT Next 5YN/A
FCF growth 1Y829.24%
FCF growth 3Y-5.24%
FCF growth 5Y-9.57%
OCF growth 1Y101.83%
OCF growth 3Y13.28%
OCF growth 5Y18.21%